Genomic Valley Biotech has informed that it has enclosed the Un-Audited Financial Results of the Company for the Quarter and Half Year ended 30th September, 2019 duly approved by the Board of Directors of the Company, at its meeting held today, the 12th day of November, 2019. The Meeting of Board of Directors of the Company commenced at 11:45 am and concluded at 02:35 pm. Also enclosed a copy of the Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.